Global Head of Regulatory Affairs
Galderma
Bhargavi is a seasoned, multi-faceted, efficient and focused Regulatory Affairs professional with an M.S in Regulatory affairs from Northeastern University and is a Pharmacist by training. Excellent knowledge of US and EU guidance, global submissions and regulatory strategic planning specializing in Oncology trials. She has worked on multiple oncology drugs including a new molecular entity that was recently approved from AstraZeneca for metastatic breast cancer patients. She is the receipt of the Marquis 2024 Who's who award for her exemplary work in the field of Regulatory affairs and advancing new medicines. She has held multiple roles within Regulatory and is currently working on advancing selinexor in myelofibrosis and endometrial cancer.
Solutions Circle (B): Evolving Health Authority Thinking on Overall Survival for Oncology Trials
Wednesday, October 8, 2025
11:15 AM - 11:45 AM EST
Solutions Circle (B): Evolving Health Authority thinking on Overall Survival for Oncology Trials
Thursday, October 9, 2025
11:15 AM - 11:45 AM EST